Searchable abstracts of presentations at key conferences in endocrinology

ea0063p636 | Interdisciplinary Endocrinology 1 | ECE2019

Helicobacter pylori infection in patients with celiac disease

Mrabet Soumaya , Jemni Imen , Akkari Imen , Jazia Elhem Ben

Introduction: Different studies indicated the possible association between celiac disease and Helicobacter pylori (HP) infection, although this evidence is not consistently accepted. The aim of our study was to determine whether HP infection and celiac disease were associated among patients undergoing upper gastrointestinal endoscopy.Methods: Between January 2017 and June 2018, patients undergoing upper gastrointestinal endoscopy with both gastric and du...

ea0063ep73 | Interdisciplinary endocrinology | ECE2019

Steatosis in chronic hepatitis C: prevalence and therapeutic impact

Mrabet Soumaya , Jemni Imen , Akkari Imen , Jazia Elhem Ben

Introduction: Steatosis has become an important issue in hepatitis C, due to the injury it can cause in a chronically ill liver. In chronic hepatitis C patients, the prevalence of steatosis ranges from 40–86%. Steatosis was significantly associated with the lack of response using PEG-IFN and ribavirin. The aim of our study was to determine the prevalence of hepatic steatosis in chronic hepatitis C and determine its impact on the therapeutic response using new direct antiv...

ea0070ep256 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Type 2 diabetes in patients with cirrhosis: Prevalence and clinical implications

Soumaya Mrabet , Akkari Imen , Jazia Elhem Ben

Introduction: Disorders of glucose metabolism are often present in chronic liver diseases. The aim of our study is to determine the prevalence and factors associated with type 2 diabetes in patients with cirrhosis.Methods: This is a retrospective study collecting all patients with cirrhosis between January 2010 and December 2019.Results: During the study period, 166 patients were included. Of these patients, 47 patients had type 2 ...

ea0081ep319 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

What is the impact of being overweight on the progressive genius of Crohn’s disease?

Akkari Imen , Ameni Hassine , Soumaya Mrabet , Elhem Ben Jazia

Background: Overweight is becoming increasingly more common among patients with inflammatory bowel disease and plays a role in the development and course of the disease especially in Crohn’s disease (CD). However, there is currently little data on his impact on the evolutionary genius of CD. The aim of this study was to assess the impact of overweight on the epidemiological, clinical, therapeutic and progressive characteristics of CD.Patients and Me...

ea0063p650 | Interdisciplinary Endocrinology 1 | ECE2019

Helicobacter pylori infection in patients with celiac disease

Jazia Elhem Ben , Mrabet Soumaya , Akkari Imen , Jemni Imen

Different studies indicated the possible association between lymphocytic gastritis and both celiac disease and Helicobacter pylori infection, although this evidence is not consistently accepted.Objective: We aimed to determine whether Helicobacter pylori infection and celiac disease were associated among patients undergoing upper gastrointestinal endoscopy.Methods: Between January 2016 and June 2017, patients over...

ea0070aep340 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Prevalence and prognosis impact of diabetes in cirrhotic patients

Samir Bradai , Akkari Imen , Soumaya Mrabet , Jazia Elhem Ben

Introduction: The prevalence of diabetes increases during cirrhosis resulting from a significant alteration in carbohydrate metabolism modifying the management of diabetes and worsening the liver prognosis. The aim of this work is to determine the prevalence of diabetes during cirrhosis, and to assess its prognostic impact on the disease.Material and method: this is a study collecting all cirrhotics followed in the gastroenterology department over a peri...

ea0070aep380 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Cryptogenic cirrhosis and metabolic syndrome: What relationship?

bradai Samir , Akkari Imen , Soumaya Mrabet , Jazia Elhem Ben

Introduction: Cryptogenic cirrhosis is cirrhosis that remains of unknown etiology after an exhaustive investigation. The relationship of cryptogenic cirrhosis with metabolic syndrome is strongly suggested. The aim of this work was to study the clinical-progressive profile of cryptogenetic cirrhosis and to determine the frequency of the metabolic syndrome.Patients and Methods: This is a study collecting all cirrhotic patients over a period of 4 years in o...

ea0073aep278 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Response to direct antiviral agents in chronic hepatitis C in patients with metabolic syndrome

Soumaya Mrabet , raida harbi , Akkari Imen , Elhem Ben Jazia

IntroductionDirect antiviral agents (DAAs) are a real revolution in the treatment of chronic hepatitis c (CHC). It is a short-term treatment with few side effects. Insulin resistance in patients with metabolic syndrome, causes the onset of steatosis, contributes to the progression to cirrhosis and decreases the chances of a response to treatment. The aim of our study was to evaluate the response to DAAs in patients with metablic syndrome.<p class="ab...

ea0073aep328 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Non alcoholic steatohepatitis related cirrhosis and hepatocellulair carcinoma: A ten years rerospective study

Soumaya Mrabet , Raida Harbi , Akkari Imen , Elhem Ben Jazia

IntroductionCurrently, the incidence of metabolic steatopathies is clearly increasing. Unlike simple fatty liver disease, non-alcoholic steatohepatitis (NASH) can progress to cirrhosis and hepatocellular carcinoma (HCC). The aim of our study was to determine the factors associated with these complications in patients with NASH.MethodsThis is a retrospective study including all cirrhotic patients followed betw...

ea0073aep358 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Impact of diabetes on liver fibrosis in chronic hepatitis C

Soumaya Mrabet , Raida Harbi , Akkari Imen , Elhem Ben Jazia

IntroductionChronic hepatitis C (CHC) is associated with an increased incidence of insulin resistance and diabetes mellitus. Obesity and insulin resistance are associated with faster progression of fibrosis in these patients. The aim of our study was to assess the impact of diabetes on the severity of hepatic fibrosis in patients followed for CHC.MethodsThis is a retrospective study conducted between January ...